Pediatric Health Dispatch, September 15, 2026

Children's National, $56.25 million from HRSA, five-year award.

Children's National announced yesterday that HRSA will award it $56.25 million over five years to co-lead the Pediatric Prevention Network, the renamed successor to the Pediatric Pandemic Network. The network total is $112.5 million across ten children's hospitals acting as regional centers, so Children's National holds exactly half. The release does not name the other co-lead, which is worth confirming before anyone cites the network structure. This is federal infrastructure money and does not belong in venture aggregates. It belongs in this edition because of what it is doing in this particular quarter. Every other federal pediatric story we have run since August has been a detachment: Executive Order 14420 restructuring the childhood vaccine schedule, the CMS rule ending federal financial participation for a category of adolescent care, the noncitizen Medicaid limits landing October 1. HRSA just renewed a children's-hospital-led network and widened its mandate to include behavioral health, children and youth with special health care needs, and rural, remote, and tribal communities. Those are precisely the populations Imagine Pediatrics, Nest Health, and Bluebird Kids Health are built around. The open question is whether any of the money leaves the hospitals, because the release names ten children's hospitals and Safe Kids Worldwide and nobody else. Defederalization is not uniform. If you have generalized from the August actions, log this as the counterexample.

iPremom, €15 million seed.

iPremom raised €15 million on September 2, led by Amadeus Capital Partners and co-led by Asabys Partners, with APEX Ventures participating. The round is euro-denominated, roughly $17 million at announcement-week rates, and it is the largest maternal-health seed we have recorded this year. It also lands after four consecutive Monday scans that surfaced no qualifying venture rounds at all. The Valencia company sells MaiRa, a test that reads cell-free RNA in maternal blood during the first trimester and returns a risk score for pregnancy complications, preeclampsia first among them. Two things make it worth more than a line. It is diagnostics rather than care delivery, which means its revenue question is a coverage and CPT question rather than a contracting-and-utilization question, and nearly every maternal-health round the vault logged this year was the latter. And the evidence base is unusual for a seed: the model was trained on more than 26,000 samples linked to roughly 10,000 pregnancies from PREMOM, one of Spain's larger prospective maternity cohorts. The caution is jurisdictional. iPremom runs the test through its own Spanish laboratory and its US regulatory path is ahead of it rather than behind it. First-trimester preeclampsia risk stratification also has an established competitive set in serum biomarker assays and a weak US payment record. Watch whether the company takes the laboratory-developed test route or files a de novo, and whether it aims at commercial maternity benefits or at the Medicaid population where preeclampsia burden is highest and price tolerance is lowest.

Pear Suite, $900,000 grant from Health Net.

Health Net awarded Pear Suite $900,000 on August 25 to help California community-based organizations build technology infrastructure, enroll as Medi-Cal providers, and get reimbursed for community health worker and doula services. Read the buyer, not the amount. Health Net is one of Centene's plans, which makes this a managed care organization paying for the administrative layer behind a benefit it is already obligated to cover. Every dollar we have tracked into Medicaid doula and community health worker delivery over the past eighteen months went to networks: recruit doulas, train doulas, match doulas to patients. Pear Suite sells the other thing entirely. Documentation, social needs assessment, referral coordination, outcome measurement, and billing workflow for organizations that were never built to be billing entities and have no reason to become them on their own. Health Net says it has now committed more than $1.9 million to Pear Suite since 2023, and that is the detail that turns a grant into a thesis. A one-time grant is charity. A third round of funding into the same vendor is a plan concluding that the binding constraint on its own benefit spend is administrative. Thursday's deep dive is built on exactly that gap, and this is a payer conceding it in public.

Luma Health and PCC, pediatric practice communications partnership, terms undisclosed.

Luma Health announced on August 19 that its communications platform is now natively integrated into Physician's Computer Company, the pediatrics-specific EHR, extending two-way multilingual family messaging to more than 300 independent pediatric practices and 1,400 pediatricians. The product is ordinary and the distribution is not. Independent pediatrics is among the most expensive channels in American healthcare to sell into, because it is thousands of small practices with no procurement function and no budget line for software that is not the EHR. PCC is one of the very few vendors built specifically for the specialty, so a native integration reaches a concentrated slice of that channel without a single practice-by-practice sale. It also sharpens a question the pediatric practice-tech category has not answered. Develo and its cohort argue that pediatrics needs a vertically integrated, pediatrics-native stack rebuilt from the ground up. Luma is making the opposite bet: pediatrics is a channel to be rented, not a vertical to be rebuilt. Both bets cannot be right. Watch whether PCC's practices actually switch the messaging workflows on, because adoption inside an installed base is where channel bets usually die.

Maven Clinic publishes high-risk pregnancy outcome benchmarks.

Not a financing, and worth the slot anyway, because it is the clearest statement yet of what a commercial maternity platform believes it is selling. Maven published an outcomes note on August 26 reporting that among 979 members with high-risk pregnancies, those who attended virtual birth-planning appointments had 59% lower odds of NICU admission and were nearly four times more likely to report active involvement in labor and delivery decisions. In its broader high-risk benchmark set, Maven reported a 13.9% NICU admission rate against 20.4% nationally and a 40.1% C-section rate against 44.4%, drawing on CDC PRAMS data across more than 9,300 Maven members and more than 5,800 privately insured national respondents. These are company-generated figures rather than independent peer-reviewed research, and Maven's public materials do not separate the effect of birth-planning visits from the effect of general program engagement. Hold the numbers loosely and the strategy tightly. NICU avoidance is the only maternity claim large enough to move an employer or health plan budget, and Maven has stopped arguing about engagement and started arguing about the most expensive line item in a pregnancy. Set it beside the Virginia doula utilization data and the contrast is structural rather than rhetorical. A commercial purchaser can buy operational support for a pregnancy and measure what it saves. A state benefit cannot buy operational support at all, because no code exists for it. Same clinical logic, two purchasing systems, and only one of them has a customer.

Eyas Medical Imaging, Ascent3T neonatal MRI, FDA 510(k) clearance.

Cleared in February and new to the vault this month, which is its own finding. Eyas received clearance on February 5 for the Ascent3T, a whole-body 3T MRI system built for neonate and infant anatomy and small enough to install inside the NICU. The Cincinnati company was founded in 2014, the system was conceived at Cincinnati Children's and built on learning gathered across more than 1,700 infant MRI scans on prototype systems, with Philips supplying electronics, software, and pulse-sequence support, and founder Charles Dumoulin holds a Cincinnati Children's pediatrics and radiology appointment. The clinical proposition is operational rather than diagnostic: stop transporting a fragile newborn down a corridor to a radiology suite designed for adults. It belongs here because it opens a sixth NICU infrastructure wedge that our May 28 piece missed. That piece sorted the category into wireless monitoring, nutrition, neuromonitoring, family workflow, and NICU-to-home, and argued that GE and Philips own the bedside while startups take everything around it. A NICU-sited 3T scanner is a startup making a claim on the bedside itself, with a Philips supply relationship rather than against one. Whether it is a business is unresolved. An April 2026 Form D describes a $2.2 million offering, private databases disagree on total capital raised by roughly a factor of two, and the Cincinnati Children's installation predates clearance and is not evidence of a commercial rollout. What we can say is that our NICU market map had a hole in it and this is what was in the hole. The map is updated.

And that is the tape. Four consecutive Monday scans have now produced zero qualifying maternal-pediatric venture rounds. The full ten-query set ran this week alongside checks against Fierce, MobiHealthNews, Behavioral Health Business, Crunchbase, and the wire services, and every promising result date-verified to 2025 or to earlier in 2026. That is a search finding rather than a claim that nothing closed, and we would rather tell you which it is than pad the section. Note what did move money this week: a federal agency and a health plan. For most of this quarter the most interesting capital in maternal-pediatric health has come from a payer, a state, a foundation, or the federal government rather than from a fund.

A Florida judge ruled that a pediatric practice can sue over how the state's actuaries did their arithmetic.

On August 26, Florida Division of Administrative Hearings Judge W. David Watkins denied the Agency for Health Care Administration's motion to dismiss and ruled that Pediatric Associates has standing to challenge the Medicaid managed care rates AHCA set in February 2025 and readjusted that November. The final hearing is October 1 and 2. The underlying dispute is about how Florida paid for moving applied behavior analysis into managed care. Pediatric Associates alleges that the state's actuaries spread ABA costs evenly across all nine Medicaid regions and all age cohorts regardless of where ABA utilization actually sits, and that this cut funding for core pediatric care by 20 to 30% in some counties, roughly 15% statewide, about $15 million a month, and nearly $300 million over twenty months. Every one of those figures is the company's allegation. The order decided standing and nothing else, and no finding has been made about whether the rates were miscalculated.

The standing question is the one that travels. AHCA argued that because Pediatric Associates is paid by managed care plans rather than by the state, its harm sits outside the Medicaid statute's zone of interests. The court rejected that. If financial harm flowing through an MCO intermediary does not defeat standing, then every capitated pediatric carve-in in every managed care state becomes contestable by the practices at the far end of the capitation. The substantive claim is the sharper one for anyone underwriting this market, because it says a behavioral health benefit was funded by shrinking the primary care share of the same capitation pool. A ten-member state ABA task force owes recommendations to the governor and Legislature by December 31.

Centene is walking away from the largest pediatric complex-care book in the country.

Florida's Children's Medical Services Health Plan, the statewide Medicaid and KidCare plan for medically complex children under 21, changes operators on October 1. Centene's Sunshine Health, which has run it statewide, exits when its contract ends September 30. Molina Healthcare of Florida takes over under a contract running through 2030. State economists project about 113,171 children in the plan, rising to 120,277 by 2030, at roughly $4,555 per member per month rising past $5,400. Sunshine Health did not lose this contract. It declined the terms, citing "concerns related to terms contained in the final version of the state's invitation to negotiate that we were not able to agree to," and then chose not to protest the award. What is on the public record is that the invitation to negotiate required the winning plan to coordinate with Hope Florida to help families leave Medicaid and KidCare, and that payment under the contract is "contingent upon availability of funds." For operators the transition is a contracting reset: every value-based or delegated-risk arrangement built with Sunshine Health for this population has to be rebuilt with Molina, whose Florida Medicaid footprint until now was Miami-Dade and Monroe counties. Note that Centene appears twice in this edition, funding Medicaid workforce infrastructure through Health Net in California and handing back a pediatric complex-care contract in Florida. Those are not contradictory. They are one company pricing two states differently, which is the state-divergence thesis we have been building all year showing up inside a single balance sheet.

Two states have said where their Meta settlement money goes, and it goes to the attorney general.

On August 26, a bipartisan coalition of 51 attorneys general announced a settlement with Meta Platforms resolving claims that Instagram and Facebook were deliberately designed to be addictive to minors. Per the attorneys general, Meta pays at least $12.1 billion to the coalition states over ten years, rising to as much as $17.1 billion if other major platforms reach comparable settlements. The settlement is subject to federal court approval and nothing disburses until that lands.

It is the largest new non-Medicaid pool of youth behavioral health money in a decade. The questions our readers need answered are which agency receives the money, whether a legislature has to appropriate it, and whether a provider can ever bill against it. Pennsylvania's share, $493 million guaranteed plus $23.8 million on a separate Cambridge Analytica claim and a maximum of $705.2 million, goes to the attorney general's office for any lawful purpose, with no legislative appropriation described. Wisconsin's share, at least $219 million and up to $313 million, will be allocated by its Department of Justice, subject to the settlement's requirement that at least half address social media harms. Nothing is earmarked for youth mental health. Permitted uses include youth mental health services, training clinicians to serve students, phone-free classrooms, and after-school programming. The commercial read is a channel call. The permitted uses skew hard toward schools, which puts school-embedded models such as Cartwheel Care and Marble Health closest to this money, and payer-backed specialty models such as Brightline furthest from it, because this is not insurance money and does not move through a benefit design. And in at least two states the entry point is not a legislative session next spring. It is an attorney general's stakeholder process that is already running.

The maternity comment window closed yesterday, and the numbers that mattered never showed up.

Comments on the CY2027 Physician Fee Schedule closed September 14. The rule recognizes the new AMA and ACOG obstetric CPT codes that split maternity billing into antepartum, labor management, delivery, and postpartum, and then proposes 15 HCPCS G-codes that would let any payer keep billing the old global bundle instead. Both sets would take effect January 1, 2027. Here is the part worth saying plainly: CMS raised the proposed values for labor and delivery and never publicly surfaced proposed antepartum and postpartum component rates. That is the seventh consecutive scan in which we have gone looking for those two numbers and not found them. Everything a maternal health company might actually bill against sits in those two components. The comment period on the largest maternity billing change in decades has now opened and closed without the public seeing the prices being commented on. That is not a conspiracy, just an unusually consequential piece of administrative opacity, and it means the comment file was written by people arguing about structure because nobody could argue about price. The final rule is expected in November and is the next chance at a number. Michigan's September bulletin, which would be the first public component rates from any state, is still unseen.

That's your Tuesday roundup. Thursday's deep dive: The Doula Coverage Trap. More than half the country now covers doula services in Medicaid, reimbursed between $459 and $1,500 per birth, and almost nobody uses them. Virginia's first two years of coverage produced doula care in fewer than 1% of eligible Medicaid births. Minnesota, which has covered doulas since 2013 under a looser design, reached 2.79%. We are going to walk the distance between a state benefit and a birth, name the specific administrative steps nobody is paid to perform, and grade our own May 3 call, which argued the map was not the revenue and turns out to have been directionally right and insufficiently grim.

Was this forwarded to you? Subscribe at pedshealthdispatch.com